Try our Advanced Search for more refined results

Pacira Pharmaceuticals, Inc. et al v. United States Food & Drug Administration et al

  1. December 15, 2015

    Pacira Settles With FDA Over Pain Drug's Off-Label Uses

    Pacira Pharmaceuticals Inc. said Tuesday it has settled its recent dispute with the U.S. Food and Drug Administration over the agency's allegedly inappropriate attempt to halt the company's off-label marketing of pain medication Exparel.

  2. October 16, 2015

    FDA Removes Pacira Warning Letter Amid Free Speech Suit

    The U.S. Food and Drug Administration has quietly unpublished a warning letter objecting to the promotional practices of Pacira Pharmaceuticals Inc., an unusual step that follows the drugmaker's constitutional challenge to restrictions on its commercial speech.

  3. September 08, 2015

    Pacira Sues FDA Over Constraints On Pain Drug's Marketing

    Pacira Pharmaceuticals Inc. on Tuesday filed a lawsuit against the U.S. Food and Drug Administration claiming the agency's unilateral attempt to quash the company's off-label marketing for pain medication Exparel violated the Administrative Procedure Act.